S. Servais Archives - Page 3 of 3

P3.06 Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation following Flu-TBI versus TLI-ATG Conditioning

BJH - volume 6, issue Abstract Book BHS, january 2015

M. Hannon , Y. Beguin MD, PhD, G. Ehx , S. Servais MD, PhD, L. Seidel , C. Graux MD, PhD, J. Maertens MD, PhD, T. Kerre MD, PhD, C. Daulne , M. De Bock , M. Fillet , A. Ory , E. Willems MD, PhD, A. Gothot MD, PhD, S. Humblet-Baron , prof. F. Baron

P4.05 High incidence of second malignancies in patients given allogeneic hematopoietic stem cell transplantation following reduced-intensity (RIC) or nonmyeloablative conditioning

BJH - volume 5, issue Abstract Book BHS, january 2014

prof. F. Baron , M. Lejeune , E. Willems MD, PhD, L. Seidel , K. Hafraoui , S. Servais MD, PhD, A. Jaspers MD, PhD, Y. Beguin MD, PhD

P4.07 Clinical and Immunological Predictive Factors of Late Infection Burden After Alternative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

BJH - volume 5, issue Abstract Book BHS, january 2014

S. Servais MD, PhD, L. Lengline , R. Porcher , M. Carmagnat , R. Peffault de Latour , M. Robin , F. Sicre de Fontebrune , E. Clave , G. Maki , J.M. Molina , A. Toubert , H. Moins-Teisserenc , G. Socie

P4.08 Disease risk index fails to predict survival after allogeneic peripheral blood stem cell transplantation (PBSCT) – Are multiple myeloma and myeloproliferative neoplasms misclassified?

BJH - volume 5, issue Abstract Book BHS, january 2014

S. Servais MD, PhD, R. Porcher , A. Xhaard , M. Robin , E. Masson , J. Larghero , P. Ribaud , N. Dhedin , G. Socie , R. Peffault de Latour

O.3 Donor Characteristics As Pretransplant Predictive Factors of Long-Term Outcomes After Allogeneic Peripheral Blood (PB) Stem Cell Transplantation (SCT) From HLA-Matched Related and Unrelated Donors in Patients with Hematologic Malignancies

BJH - 2013, issue BHS Abstractbook, january 2013

S. Servais MD, PhD, R. Porcher , M. Robin , A. Xhaard , E. Masson , J. Larghero , R. Ribaud , G. Socie , R. Peffault de Latour

P.70 Immune Reconstitution After Alternative Hematopoietic Stem Cell Transplantation: Comparison of Unrelated Cord Blood (CB) and Mismatched Unrelated Donor (mmUD) Stem Cell Transplantation (SCT)

BJH - 2013, issue BHS Abstractbook, january 2013

S. Servais MD, PhD, C. Granier , M. Robin , A. Xhaard , R. Peffault de Latour , G. Socie

S. Servais MD, PhD

Articles

P3.06 Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation following Flu-TBI versus TLI-ATG Conditioning

P4.05 High incidence of second malignancies in patients given allogeneic hematopoietic stem cell transplantation following reduced-intensity (RIC) or nonmyeloablative conditioning

P4.07 Clinical and Immunological Predictive Factors of Late Infection Burden After Alternative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

P4.08 Disease risk index fails to predict survival after allogeneic peripheral blood stem cell transplantation (PBSCT) – Are multiple myeloma and myeloproliferative neoplasms misclassified?

O.3 Donor Characteristics As Pretransplant Predictive Factors of Long-Term Outcomes After Allogeneic Peripheral Blood (PB) Stem Cell Transplantation (SCT) From HLA-Matched Related and Unrelated Donors in Patients with Hematologic Malignancies

P.70 Immune Reconstitution After Alternative Hematopoietic Stem Cell Transplantation: Comparison of Unrelated Cord Blood (CB) and Mismatched Unrelated Donor (mmUD) Stem Cell Transplantation (SCT)